FlexSys, FlexSys UVB EPL 308 nm, FlexSys UVB EPL lite 308 nm, FlexSys IR 1550 nm

The FlexSys UVB EPL 308 nm and FlexSys UVB EPL Lite 308 nm devices are specifically designed for localized ultraviolet B (UVB) phototherapy, which is commonly used to treat dermatological conditions such as psoriasis, vitiligo, and other skin disorders requiring targeted UVB light exposure. The UVB modules emit narrowband light at 308 nm to address these conditions, while the IR 1550 nm module targets superficial tissue effects, often used in conjunction with UVB for complementary therapeutic benefits.

The FlexSys system is supplied as a modular device, allowing clinicians to combine UVB and IR phototherapy modules based on their treatment needs. According to the manufacturer’s specifications, the modules can be configured for either single-use or reusable applications, though the exact reuse guidelines depend on the specific module and must be followed as outlined in the manufacturer’s instructions. There is no explicit sterility classification provided, so standard medical device handling protocols should be adhered to.

The FlexSys UVB EPL 308 nm, FlexSys UVB EPL Lite 308 nm, and FlexSys IR 1550 nm devices have undergone FDA 510(k) clearance (K221623) and comply with the Medical Device Directive (MDD). This means the devices are considered substantially equivalent to predicate devices and meet EU regulatory requirements for marketing. Clinicians can rely on these clearances to ensure the devices meet established safety and performance standards for dermatological phototherapy applications.

The FlexSys system includes three distinct modules: the UVB EPL 308 nm, UVB EPL Lite 308 nm, and IR 1550 nm. The primary difference lies in their wavelength and intended application—UVB modules target localized UVB treatment, while the IR 1550 nm module delivers infrared phototherapy for superficial tissue effects. The